: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

Your Kind of Day?

Thu, 05 Nov 2009 19:06:48 GMT

As a rule, I try not to read too terribly much into a "Fed Day" as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on "Fed Days." But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.[More...]

The Dollar-Proof Portfolio

Thu, 05 Nov 2009 17:31:14 GMT

Don't put off this important piece of the financial-planning process.[More...]

What Investors Should Look for In Today’s Fed Statement

Wed, 04 Nov 2009 13:04:24 GMT

In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).[More...]

Are Discount Brokers Shares Worth Owning?

Wed, 04 Nov 2009 01:28:03 GMT

The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&P gain 15%.[More...]

Technology Rises And Buying Facebook

Tue, 03 Nov 2009 16:54:11 GMT

Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%. Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.[More...]

Buffett Gets His Cheque Book Out

Tue, 03 Nov 2009 16:17:34 GMT

Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.[More...]

Five Ways To Ride The Commodities Bull

Tue, 03 Nov 2009 15:21:07 GMT

Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over. Don’t believe it.[More...]

Beware, Many Stolen Computers Have Tracking Software

Mon, 26 Oct 2009 14:50:00 GMT

Oct. 26--LAWRENCE -- At $250, the laptop computer purchased on the street appeared to be a good deal.
But when officers showed up at Aileen Acevedo's Brook Street home with a search warrant seeking the computer a few nights later, she learned it was stolen from Lahey Clinic in Burlington, police said.
As with most computers being manufactured now, the Fujitsu Tablet laptop was equipped with tracking software which can pinpoint a stolen computer to any address.

: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Your Kind of Day?

The Dollar-Proof Portfolio

What Investors Should Look for In Today’s Fed Statement

Are Discount Brokers Shares Worth Owning?

Technology Rises And Buying Facebook

Buffett Gets His Cheque Book Out

Five Ways To Ride The Commodities Bull

Beware, Many Stolen Computers Have Tracking Software

Boston Scientific returns to profit in 3rd qtr

Sliding Dollar May Be Something to Cheer About

Abbott Reports Earnings Gain on Stronger Sales, Settlement of Patent Suit: W.W. Grainger Reports Revenue Continues to Fall

Abbott Profit Up 37% on Patent Settlement, Humira Sales

Humira and nutrition sales lift Abbott 3Q profit

St. Louis Post-Dispatch, David Nicklaus Column

Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth

Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth

BosSci Paying $716M to J&J: Action Resolves Some, but Not All, Heart Stent Suits

Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets

Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio

Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy

Medtronic Reports First Quarter Revenue of $3.9 Billion

Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent

Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market

StreetSmart Strategies®, a Management Consulting Firm, Retains Veteran Corporate Investor Relations Officer David Prichard

Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial

Impax Laboratories Receives Final FDA Approval for Generic Depakote® Extended-Release 500mg Tablets

Absolute Refutes Claims of BIOS Vulnerability

Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: ALBAN CARLOS (10K)

Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: Mason Heather L (10K)

Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Warmuth Michael J (10K)

Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Fussell Stephen R (10K)

Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: ROBERTS ROY S (10K)

Form 4 ABBOTT LABORATORIES For: Oct 16 Filed by: Patton Donald V JR (10K)

Form 4 ABBOTT LABORATORIES For: Oct 16 Filed by: Warmuth Michael J (10K)

Form 4 ABBOTT LABORATORIES For: Oct 15 Filed by: ALBAN CARLOS (10K)

Form 3 ABBOTT LABORATORIES For: Oct 15 Filed by: ALBAN CARLOS (10K)

Form 4 OSBORN WILLIAM A For: Sep 30 (10K)